High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy
- PMID: 2927654
- DOI: 10.1212/wnl.39.3.422
High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy
Abstract
We treated nine consecutive patients with chronic inflammatory demyelinating polyneuropathy (CIDP) with high-dose intravenous human immunoglobulin (HIG), and clinical recovery rapidly followed. Disability that had persisted for months or years was often reversed in days. There were no major adverse reactions to HIG infusions.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical